Gerald D. Cagle

Gerald D. Cagle, PhD has served as a member of our board of directors since September 2013. Dr. Cagle is currently Chief Operating Officer at Cognoptix, lnc., focused on the diagnosis of Alzheimer’s disease. He also is Senior Advisor and Head of Business Development for GrayBug, LLC, a platform drug delivery company. Previously, Dr. Cagle served as Senior Vice President of Research & Development at Alcon Laboratories lnc. from 1997 to 2008, assuming the responsibility of Chief Scientific Officer in 2006. Dr. Cagle has served on the Wilmer Eye Institute Advisory Council and is a member of the ARVO Foundation Board of Governors. Dr. Cagle received his BS degree from Wayland College and earned both his MS and PhD degrees from the University of North Texas. We believe that Dr. Cagle’s scientific background and experience provides him with the qualifications and skills to serve as a member of our board of directors.

Gerald D. Cagle is the COO, Cognoptix Inc.; Former SVP, Research & Development; CSO, Alcon Laboratories Inc. at Aerie Pharmaceuticals. With a background in Biotechnology, Gerald D. Cagle has a rich history of leadership and innovation.Gerald D. Cagle studied unknown unknown at University of North Texas. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.